The cyber risk sector is constantly evolving, and it is crucial for reinsurers to keep up with the latest developments in the space. Looking toward the remainder of 2020 as COVID-19 upends how businesses interact with technology, the reinsurance market sees a number of emerging trends.
Life sciences and technology companies are increasingly aligning to pursue advances in life science technology that enhance the quality, speed and sophistication of patient care. However, these advances also introduce new cybersecurity risks and regulatory oversight that must be managed. And, in the COVID-19 era, the use of medical tracking and diagnostic technologies intensifies the need to address such risks.
On a recent webcast, Marsh and leading policy, cybersecurity and legal authorities discussed how manufacturers, providers and other health care ecosystem stakeholders can manage these complex cybersecurity and regulatory issues – and protect themselves from potential liabilities. Marsh is an affiliate of Guy Carpenter.
Guy Carpenter’s Cyber Global Center of Excellence is actively following and responding to significant developments in the cyber risk sphere and helping clients adapt to evolving technologies.